Skip to main content

Table 2 Summary of the characteristics of the includes studies

From: The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review

Study

N included

N completed treatment

Population and primary diagnosis

Treatment types

Duration (weeks)

Primary and secondary outcome measure

Time between pre- and post-treatment

Blom et al. (2007)

193

132

Adults with MDD

IPT vs.Nefazodone vs.IPT+nefazodone vs.IPT+placebo

16

HAMD

12 weeks

MADRS

Elkin et al. (1989)

250

155

Adults with MDD

IPT vs. CBT vs. IMI-CM vs. PLA-CM

16

HRSD

16 weeks

BDI

Luty et al. (2009)

177

159

Adults with MDD

IPT vs.CBT

16

MADRS

16 weeks

HRSD

 

BDI

 

Marshall et al. (2008)

159

102

Adults with MDD

IPT vs.CBT vs.PHT-CM

16

HRSD

16 weeks

Martin et al. (2001)

28

28

Adults with MDD

IPT vs.Venlafaxine

16

HAMD

6 weeks

BDI

O’Hara et al. (2000)

120

99

Women with PPD

IPT vs. WLC

12

HRSD

12 weeks

BDI

Schramm et al. (2011)

30

29

Adults with early onset chronic MDD

IPT vs.CBASP

16 with 12 months follow-up

HRSD

16 weeks

BDI

 

Schulberg et al. (1996)

276

150

Adults with MDD

IPT vs.Nortriptyline vs.Usual care

16 with 8 months follow-up

HRSD

8 months

  1. CBASP Cognitive Behavioral Analysis System of Psychotherapy; CBT Cognitive Behavior Therapy; HAMD Hamilton Depression Rating Scale; HRSD Hamilton Rating Scale Depression; IMI-CM imipramine plus clinical management; IPT Interpersonal Psychotherapy; MADRS Montgomery-Ã…sberg Depression Rating Scale; MDD Major Depressive Disorder; PHT-CM pharmacotherapy plus clinical management; PLA-CM placebo plus clinical management; WLC wait list condition.